Logo

Dyadic Partners With Scripps Florida to Annotate Genome of Dyadic s C1 Fungus Genome

Mar 31, 2006

NEW YORK, March 31 (GenomeWeb News) - Dyadic International announced today that it will work with the Scripps Research Institute to provide a complete annotation of the genome of Chrysosporium lucknowense, Dyadic's proprietary fungal organism.

 

The organism, also known as C1, was sequenced last year by Agencourt Biosciences, a wholly owned subsidiary of Beckman Coulter.

 

The genome annotation work will be carried out at Scripps' new research center in Palm Beach County, Fla., under the direction of Nick Tsinoremas, senior director of Informatics at Scripps Florida, Dyadic said.

 

Financial details of the agreement were not disclosed.

Breaking News
The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.